Nipro Corp - Company Profile

Powered by

All the sales intelligence you need on Nipro Corp in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Nipro Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Nipro Corp.

Back to companies

Nipro Corp: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

Nipro Corp (Nipro) develops, manufactures, and distributes medical devices, pharmaceuticals, and pharmaceutical packaging. The company’s products include renal products, interventional and anaesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, and half-type kits among others. It offers contract manufacturing services of development, manufacturing of drug formulations, inspection, packaging, logistics and distribution services. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass-forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia, and Africa. Nipro is headquartered in Settsu, Osaka, Japan.

 Gain a 360-degree view of Nipro Corp and make more informed decisions for your business Gain a 360-degree view of Nipro Corp and make more informed decisions for your business Learn more
Headquarters Japan
Address 3-26, Senrioka Shin-Machi, Settsu, Osaka, 566-8510
Website www.nipro.co.jp
Telephone 81 6 63106804
No of Employees 38,593
Industry Medical Equipment
Ticker Symbol & Exchange 8086 (TYO)
Revenue (2025) $4.2B 2.5% (2025 vs 2024)
EPS XYZ
Net Income (2025) XYZ 164% (2025 vs 2024)
Market Cap* $1.6B
Net Profit Margin (2025) XYZ 158.2% (2025 vs 2024)
* As of and is in US$
View Nipro Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Nipro Corp premium industry data and analytics

30+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Nipro Corp (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Services Brands
Medical-Related Contract Development and Manufacturing Services NSE
Renal Citrasate
Dialyzers Biohole
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Nipro Corp portfolio and identify potential areas for collaboration Understand Nipro Corp portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Regulatory Approval In September, the company secured manufacturing and marketing approval for CB Pack Continuous Blood Purification Solution.
2026 Regulatory Approval In September, the company secured marketing authorization for its biosimilar product, Ustekinumab BS Intravenous Infusion 130mg, Nipro.
2026 Corporate Changes/Expansions In September, the company established its headquarters in Singapore by incorporating the NIPRO Asia Pacific Group.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Nipro Corp Fresenius SE & Co KGaA Chugai Pharmaceutical Co Ltd Terumo Corp Kyowa Kirin Co Ltd
Headquarters Japan Germany Japan Japan Japan
City Settsu Bad Homburg Chuo-Ku Shibuya-Ku Chiyoda-Ku
State/Province Osaka Hessen Tokyo Tokyo Tokyo
No. of Employees 38,593 178,486 7,872 31,185 5,161
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Yoshihiko Sano Chairman Executive Board 2025 81
Takeshi Yamazaki Chief Executive Officer; President; Director Executive Board 2023 58
Takahiro Oichi President; Director Executive Board 2026 -
Nishisako Hideyuki Director; General Manager - PharmaPackaging Division Executive Board - -
Yoneda Atsushi Chief of Production Technology Center; Director Executive Board - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Nipro Corp key executives to enhance your sales strategy Gain insight into Nipro Corp key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?